New peptide (SEQ ID n ° 236), peptide combination and scaffold for immunotherapy of various cancers. （Divisional request 201800545）

摘要

The invention relates to qualification (SEO ID NO; 236),Proteins, nucleic acids and erythema used in immunotherapy. In particular, the current invention is immunotherapy for cancer. The invention also relates to xanthosis of tumor related T-lymphocytes, which alone or in combination with other tumor related peptides, for example, can be used as the active drug principle in vaccine ingredients to stimulate the anti-tumor immune response, Or stimulate pre live T cells they will be transferred to the patient. Peptides that bind to the maximum histocompatibility (MHC) complex molecules,Infertility itself may also be an antibody target, soluble lymphocyte receptor and other single cell targets.